| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee7f2a46b44ab1338a7673c74c7831eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_144f594513aec7b42679f432e92531e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1d4eca87761b4e0b42c4fb9c8af64c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51ab81f7ca11c5ce376fb4563f96812b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_347b85197c14984df647a169e71e07bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2011-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcb66794d8e5696a4f816e577747cdad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e9a4d3e5c6fb9119265c5ec8a0caee8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1acb04c83d3fa3e2bd720908a4712165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4300c9631648d7c48cca2de758348ee2 |
| publicationDate |
2014-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8741312-B2 |
| titleOfInvention |
High yield yellow fever virus strain with increased propagation in cells |
| abstract |
The invention provides a an inactive, non-replicating vaccine comprising whole virion, chemically inactivated Yellow Fever virus which is inactivated using a method that ensures preservation of critical, neutralizing epitopes. The Yellow Fever virus has been adapted to propagate in cells to higher yields than the unadapted virus. The invention also provides methods for preventing Yellow Fever viral infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023283593-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017210215-A1 |
| priorityDate |
2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |